Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study Teriparatide and Antiresorptive Combination Treatment Subsequent to 9 Months of Teriparatide Monotherapy

NCT01535027 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT01535027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01535027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study Teriparatide and Antiresorptive Combination Treatment Subsequent to 9 Months of Teriparatide Monotherapy
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2006
Completion date
December 31, 2012
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis